Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: de novo designed disease resistance gene

PROVIDER: PRJNA1148303 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR30328916_1.fastq.gz	Fastqsanger.gz
	SRR30328916_2.fastq.gz	Fastqsanger.gz
	SRR30328917_1.fastq.gz	Fastqsanger.gz
	SRR30328917_2.fastq.gz	Fastqsanger.gz
	SRR30328918_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Project description:A de novo designed disease resistance gene

| PRJNA1027554 | ENA

De novo AMR resistance in E. coli

Project description:De novo resistance emergence

| PRJEB85246 | ENA

Project description:Deep mutational scanning of a de novo designed membrane transporter

| PRJNA666943 | ENA

Fecal microbiome alterations in treatment-naïve de novo Parkinson’s disease

Project description:Gut microbiota de novo Parkinson's disease

| PRJEB55464 | ENA

Whole genome bisulfite sequencing data of cassava

Project description:Cassava mosaic disease (CMD) suppresses cassava yields across the tropics. It has been reported that landraces lose CMD resistance after regeneration through de novo morphogenesis. We sequenced WGBS data of 14 samples.

2022-05-27 | GSE192748 | GEO

NovoBoard: a comprehensive framework for evaluating the false discovery rate and accuracy of de novo peptide sequencing

Project description:De novo peptide sequencing is a fundamental research area in mass spectrometry (MS) based proteomics. However, those methods have often been evaluated using a couple of simple metrics that do not fully reflect their overall performance. Moreover, there has not been an established method to estimate the false discovery rate (FDR) and the significance of de novo peptide-spectrum matches (PSMs). Here we propose NovoBoard, a comprehensive framework to evaluate the performance of de novo peptide sequencing methods. The framework consists of diverse benchmark datasets (including tryptic, nontryptic, immunopeptidomics, and different species), and a standard set of accuracy metrics to evaluate the fragment ions, amino acids, and peptides of the de novo results. More importantly, a new approach is designed to evaluate de novo peptide sequencing methods on target-decoy spectra and to estimate their FDRs. Our results thoroughly reveal the strengths and weaknesses of different de novo peptide sequencing methods, and how their performances depend on specific applications and the types of data. Our FDR estimation also shows that some tools may perform better than the others in distinguishing between de novo PSMs and random matches, and can be used to assess the significance of de novo PSMs.

2024-08-28 | PXD055277 | Pride

E-GEOD-50694

Project description:Endocrine response in invasive lobular carcinoma is characterized by unique estrogen-mediated gene expression and de novo tamoxifen resistance (SUM44)

2025-01-24 | E-GEOD-50694 | ExpressionAtlas

E-GEOD-50693

Project description:Endocrine response in invasive lobular carcinoma is characterized by unique estrogen-mediated gene expression and de novo tamoxifen resistance (MM134)

2025-01-24 | E-GEOD-50693 | ExpressionAtlas

Epigenetic characteristics and gene-expression analysis of Derivative 3-3 de novo centromere in maize

Project description:De novo centromeres originate occasionally from non-centromeric regions of chromosomes, providing an excellent model system to study centromeric chromatin. The maize mini-chromosome Derivative 3-3 contains a de novo centromere, which was derived from a euchromatic site on the short arm of chromosome 9 that lacks traditional centromeric repeat sequences. Our previous study found that the CENH3 binding domain of this de novo centromere is only 288 kb with a high-density gene distribution with low-density of transposons. Here we applied next generation sequencing technology to analyze gene transcription, DNA methylation for this region. Our RNA-seq data revealed that active chromatin is not a barrier for de novo centromere formation. Bisulfite-ChIP-seq results indicate a slightly increased DNA methylation level after de novo centromere formation, reaching the level of a native centromere. These results provide insight into the mechanism of de novo centromere formation and subsequent consequences. RNA-seq was carried out using material from seedling and young leaves between control and Derivative 3-3. Bisulfite-ChIP-seq was carried out with anti-CENH3 antibodies using material from young leaves in Derivative 3-3.

2016-08-05 | E-GEOD-76533 | biostudies-arrayexpress

Project description:De novo-designed binder-based CAR T cells enable effective targeting of glioblastoma

| PRJNA935143 | ENA